PREVALENCE OF ISOLATED INCOMPLETE CLEFT LIP AMONG THE PATIENTS OF PRIVATE DENTAL COLLEGE
DOI:
https://doi.org/10.61841/8e1wh182Keywords:
Cleft lip and palate, isolated cleft lip, teratogens, orofacial cleftsAbstract
Cleft lip and/ or palate are the most common facial congenital anomaly.Approximately 50% of cases born with cleft lip and palate occur due to a known genetic syndrome or with another malformation (e.g., congenital heart defects) and the other 50% occur as solitary defects, referred to often as non-syndromic clefts. Etiology for cleft lip or palate is multifactorial.Several in vitro studies have shown that the molecular pathways are responsible for proper closure of the palate, including the BMP, TGF-β, and SHH signaling pathways. Any disturbance in these pathways can cause clefting of lips or palate. In terms of environmental exposures, maternal tobacco smoke has been found to be strongly associated with cleft lips and palate. Some studies have suggested that maternal glucocorticoid exposure may also play a vital role. Isolated incomplete form of cleft lip is a rare form of cleft lip.There is a need for more epidemiologic studies to further investigate both etiology and treatment for isolated incomplete cleft lips as well as other types of cleft lips and palate. The objective of the study is to evaluate the prevalence of isolated incomplete cleft lip in patients reported to a private dental college.The patients with the diagnosis of cleft lip were randomly selected for the study. From the total sample size 86000 patients after implementing inclusion and exclusion criteria, a sample size of 27 patients were considered for this study. Compiled data was statistically analysed. In our study, isolated incomplete cleft lip was prevalent for only 33.3%.Whereas the other cleft lip which includes unilateral and bilateral cleft 66.7% together.Within the limitations, this study shows that there was only minimal prevalence of isolated incomplete cleft lip.Even though the prevalence of complete and incomplete cleft lip and palate are more common all over the world ,we felt that the incidence of isolated incomplete cleft lip is not least common,its prevalence of 33.3% is an indicator for performing further studies regarding its embryological and genetic basis.
Downloads
References
[1] Parker SE, Mai CT, Canfield MA. Updated national birth prevalence estimates for selected birth defects in the United States, 2004–2006. Research Part A [Internet]. 2010; Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/bdra.20735
[2] Mai CT, Isenburg JL, Canfield MA, Meyer RE, Correa A, Alverson CJ, et al. National population-based estimates for major birth defects, 2010–2014. Birth Defects Research. 2019;111(18):1420–35.
[3] Little J, Cardy A, Munger RG. Tobacco smoking and oral clefts: a meta-analysis. Bull World Health Organ. 2004 Mar;82(3):213–8.
[4] Honein MA, Rasmussen SA, Reefhuis J, Romitti PA, Lammer EJ, Sun L, et al. Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology. 2007 Mar;18(2):226–33.
[5] Correa A, Gilboa SM, Besser LM, Botto LD, Moore CA, Hobbs CA, et al. Diabetes mellitus and birth defects. Am J Obstet Gynecol. 2008 Sep;199(3):237.e1–9.
[6] De La Pedraja J, Erbella J, McDonald WS, Thaller S. Approaches to cleft lip and palate repair. J Craniofac Surg. 2000 Nov;11(6):562–71.
[7] Drillien CM, Jameson S, Wilkinson EM. Studies in mental handicap. I. Prevalence and distribution by clinical type and severity of defect [Internet]. Vol. 41, Archives of Disease in Childhood. 1966. p. 528–38. Available from: http://dx.doi.org/10.1136/adc.41.219.528
[8] Parada C, Chai Y. Roles of BMP signaling pathway in lip and palate development. Front Oral Biol. 2012 Jun 25;16:60–70.
[9] Dixon MJ, Marazita ML, Beaty TH, Murray JC. Cleft lip and palate: understanding genetic and environmental influences. Nat Rev Genet. 2011 Mar;12(3):167–78.
[10] Murray JC. Gene/environment causes of cleft lip and/or palate. Clin Genet. 2002 Apr;61(4):248–56.
[11] Beaty T. Faculty Opinions recommendation of Nucleotide variants of the cancer predisposing gene CDH1 and the risk of non-syndromic cleft lip with or without cleft palate [Internet]. Faculty Opinions – Post Publication Peer Review of the Biomedical Literature. 2016. Available from: http://dx.doi.org/10.3410/f.726950482.793525249
[12] Osoegawa K, Vessere GM, Utami KH, Mansilla MA, Johnson MK, Riley BM, et al. Identification of novel candidate genes associated with cleft lip and palate using array comparative genomic hybridisation. J Med Genet. 2008 Feb;45(2):81–6.
[13] Suzuki S, Marazita ML, Cooper ME, Miwa N, Hing A, Jugessur A, et al. Mutations in BMP4 are associated with subepithelial, microform, and overt cleft lip. Am J Hum Genet. 2009 Mar;84(3):406–11.
[14] Shi M, Wehby GL, Murray JC. Review on genetic variants and maternal smoking in the etiology of oral clefts and other birth defects. Birth Defects Res C Embryo Today. 2008 Mar;84(1):16–29.
[15] DeRoo LA, Wilcox AJ, Drevon CA. First-trimester maternal alcohol consumption and the risk of infant oral clefts in Norway: a population-based case-control study [Internet]. 2008; Available from: https://academic.oup.com/aje/article-abstract/168/6/638/89295
[16] Herkrath APC de Q, Herkrath FJ, Rebelo MAB, Vettore MV. Parental age as a risk factor for non-syndromic oral clefts: a meta-analysis. J Dent. 2012 Jan;40(1):3–14.
[17] Kelly D, O’Dowd T, Reulbach U. Use of folic acid supplements and risk of cleft lip and palate in infants: a population-based cohort study. Br J Gen Pract. 2012 Jul;62(600):e466–72.
[18] Wilcox AJ, Lie RT, Solvoll K, Taylor J, McConnaughey DR, Abyholm F, et al. Folic acid supplements and risk of facial clefts: national population based case-control study. BMJ. 2007 Mar 3;334(7591):464.
[19] Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, et al. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med. 2010 Jun 10;362(23):2185–93.
[20] Rahman R, Mp SK. Knowledge, attitude, and awareness of dental undergraduate students regarding human immunodeficiency virus/acquired … Asian J Pharm Clin Res [Internet]. 2017; Available from: https://innovareacademics.org/journals/index.php/ajpcr/article/download/17277/10802
[21] Kumar S, Sneha S. Knowledge and awareness regarding antibiotic prophylaxis for infective endocarditis among undergraduate dental students [Internet]. Asian J Pharm Clin Res. 2016;9(S2):154. Available from: http://dx.doi.org/10.22159/ajpcr.2016.v9s2.13405
[22] Patturaja K, Pradeep D. Awareness of Basic Dental Procedure among General Population [Internet]. Vol. 9, Research Journal of Pharmacy and Technology. 2016. p. 1349. Available from: http://dx.doi.org/10.5958/0974-360x.2016.00258.4
[23] Kumar S, Rahman R. Knowledge, awareness, and practices regarding biomedical waste management among undergraduate dental students [Internet]. Vol. 10, Asian J Pharm Clin Res. 2017. p. 341. Available from: http://dx.doi.org/10.22159/ajpcr.2017.v10i8.19101
[24] Christabel A, Anantanarayanan P, Subash P, Soh CL, Ramanathan M, Muthusekhar MR, et al. Comparison of pterygomaxillary dysjunction with tuberosity separation in isolated Le Fort I osteotomies: a prospective, multi-centre, triple-blind, randomized controlled trial [Internet]. Vol. 45, Int J Oral Maxillofac Surg. 2016;180–5. Available from: http://dx.doi.org/10.1016/j.ijom.2015.07.021
[25] Jain SV, Vijayakumar Jain S, Muthusekhar MR, Baig MF, Senthilnathan P, Loganathan S, et al. Evaluation of three-dimensional changes in pharyngeal airway following isolated Lefort one osteotomy for the correction of vertical maxillary excess: A prospective study [Internet]. Vol. 18, J Maxillofac Oral Surg. 2019;139–46. Available from: http://dx.doi.org/10.1007/s12663-018-1113-4
[26] Abhinav RP, Selvarasu K, Maheswari GU, Taltia AA. The patterns and etiology of maxillofacial trauma in South India. Ann Maxillofac Surg. 2019 Jan;9(1):114–7.
[27] Marimuthu M, Andiappan M, Wahab A, Muthusekhar MR, Balakrishnan A, Shanmugam S. Canonical Wnt pathway gene expression and their clinical correlation in oral squamous cell carcinoma. Indian J Dent Res. 2018 May;29(3):291–7.
[28] Jesudasan JS, Abdul Wahab PU, Muthu Sekhar MR. Effectiveness of 0.2% chlorhexidine gel and a eugenol-based paste on postoperative alveolar osteitis in patients having third molars extracted: a randomised controlled clinical trial [Internet]. Vol. 53, Br J Oral Maxillofac Surg. 2015;826–30. Available from: http://dx.doi.org/10.1016/j.bjoms.2015.06.022
[29] Packiri S, Gurunathan D, Selvarasu K. Management of paediatric oral ranula: A systematic review. J Clin Diagn Res. 2017 Sep;11(9):ZE06–9.
[30] Patil SB, Durairaj D, Suresh Kumar G, Karthikeyan D, Pradeep D. Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: A prospective pilot study [Internet]. Vol. 16, J Maxillofac Oral Surg. 2017;312–21. Available from: http://dx.doi.org/10.1007/s12663-016-0975-6
[31] Rao TD, Santhosh Kumar MP. Analgesic efficacy of paracetamol vs ketorolac after dental extractions [Internet]. Vol. 11, Res J Pharm Technol. 2018;3375. Available from: http://dx.doi.org/10.5958/0974-360x.2018.00621.2
[32] Kumar S. Relationship between dental anxiety and pain experience during dental extractions [Internet]. Vol. 10, Asian J Pharm Clin Res. 2017;458. Available from: http://dx.doi.org/10.22159/ajpcr.2017.v10i3.16518
[33] Kumar S. The emerging role of botulinum toxin in the treatment of orofacial disorders: Literature update [Internet]. Vol. 10, Asian J Pharm Clin Res. 2017;21. Available from: http://dx.doi.org/10.22159/ajpcr.2017.v10i9.16914
[34] Farhat Yaasmeen Sadique Basha, Rajeshkumar S, Lakshmi T. Anti-inflammatory activity of Myristica fragrans extract. Int J Res Pharm Sci. 2019;10(4):3118–20. DOI: https://doi.org/10.26452/ijrps.v10i4.1607
[35] Sweta VR, Abhinav RP, Ramesh A. Role of virtual reality in pain perception of patients following the administration of local anesthesia. Ann Maxillofac Surg. 2019;9(1):110–113.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
